HIVID FILM-COATED TABLES 0.75MG

AU:D J05AF03(WHO) UK:POM(Prescription only)US:℞-onlyIn general: ℞ (Prescription only) 4-amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 7481-89-2Y 24066 4828 DB00943Y 22498Y 6L3XT8CB3I D00412Y CHEBI:10101Y ChEMBL853Y 000006 DTXSID0023747 Interactive image O=C1/N=C(/N)\C=C/N1[C@@H]2O[C@@H](CC2)CO InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1YKey:WREGKURFCTUGRC-POYBYMJQSA-NY Zalcitabine(2′-3′-dideoxycytidine,ddC), also called dideoxycytidine, is a nucleoside analogreverse-transcriptase inhibitor(NRTI) sold under the trade nameHivid. Zalcitabine was the third antiretroviral to be approved by the Food and Drug Administration (FDA) for the treatment ofHIV/AIDS. It is used as part of acombination regimen. Zalcitabine appears less potent than some other nucleoside RTIs, has an inconvenient three-times daily frequency and is associated with serious adverse events. For these reasons it is now rarely used to treat human immunodeficiency virus (HIV), and it has even been removed from pharmacies entirely in some countries.